Weebit Nano (ASX:WBT): FY26 was amazing…plenty more where that came from!

We spoke to Weebit Nano CEO, Coby Hanoch, about the amazing year that FY26 has been. Revenues ended up at

Weebit Nano (ASX:WBT) is now firmly on the radar screens of international institutional investors!

We caught up with Coby Hanoch, CEO of Weebit Nano (ASX:WBT), and spoke about the progress with existing customers and

DorsaVi hits the road toward 22nm ReRAM

We spoke to Mathew Regan, Group CEO of DorsaVi (ASX:DVL), about DVL's announcement that 3 ReRAM material stacks have successfully

Amaero (ASX:3DA) is helping to build the “Arsenal of Democracy 2.0”

We spoke to Hank Holland, CEO of Amaero (ASX:3DA), about the opportunity his company is developing to move from just

Temas Resources (ASX:TIO) can obtain titanium and other metals very cost-effectively with RCL

We spoke with Tim Fernback, CEO of Temas Resources (ASX:TIO), about the strong demand for titanium in advanced industrial applications,

BluGlass presented at the Pitt Street Research Semiconductor Conference 2026

BluGlass CEO Jim Haden presented at the Pitt Street Research Semiconductor Conference 2026.

Nanoveu presented at the Pitt Street Research Semiconductor Conference 2026

Nanoveu's founder Mohamed Sabry presented at the 2026 edition of the Pitt Street Research Semiconductor Conference.

Weebit Nano presented at the Pitt Street Research Semiconductor Conference 2026

Weebit Nano's CEO Coby Hanoch presented at the 2026 edition of the Pitt Street Research Semiconductor Conference.

Weebit Nano (ASX:WBT) is getting ready for the big time with an $80m capital raise!

We spoke to Weebit Nano CEO Coby Hanoch about the company's recent capital raise and how that sets it up

DorsaVi (ASX:DVL) unveiled its ambitious 22nm ReRAM strategy: Interview with Group CEO Mathew Regan

We spoke to DorsaVi's Group CEO, Mat Regan, about the company's new research collaboration with ITRI in Taiwan, and how

Unicycive Therapeutics (Nasdaq:UNCY) has big plans for its lead candidate OLC

Unicycive Therapeutics (Nasdaq:UNCY) is a clinical-stage biotech company based in Los Altos, CA. The company's lead candidate is oxylanthanum carbonate

Weebit Nano signs license deal with Texas Instruments: Interview with CEO Coby Hanoch

We spoke with Coby Hanoch, CEO of RERAM IP company Weebit Nano (ASX:WBT), about the license deal Weebit Nano just

Island Pharmaceuticals (ASX:ILA) spoke at the Pitt Street Research Life Sciences Conference 2024

On 1 October 2024, Island Pharmaceuticals (ASX:ILA) Executive Chairman Dr. Paul MacLeman spoke at the Pitt Street Research Life Sciences

Battery Age Minerals (ASX:BM8) reports much higher than expected germanium grades

We spoke with Nigel Broomham, CEO of Battery Age Minerals (ASX: BM8), about the company's recent analysis of a government

Black Rock Mining (ASX:BKT) CEO John de Vries speaks with Stocks Down Under

On 26 September 2024 we spoke with John de Vries, CEO of Black Rock Mining (ASX: BKT), about the debt
Register for the Conference